STOCK TITAN

Nu Skin (NUS) director sells 7,203 shares and gets 26,643-share grant

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

NU SKIN ENTERPRISES, INC. director Edwina D. Woodbury reported both a sale and a stock grant of Class A Common Stock. On June 1, 2026, she executed an open-market sale of 7,203 shares at $5.70 per share. The same day, she acquired 26,643 shares through a grant or award at no stated purchase price. Following these transactions, her direct holdings totaled 69,636 shares of Class A Common Stock. The footnote states the sale occurred under a pre-arranged trading plan intended to comply with Rule 10b5-1(c) adopted on February 19, 2026, indicating the sale’s timing was planned in advance.

Positive

  • None.

Negative

  • None.
Insider WOODBURY EDWINA D
Role null
Sold 7,203 shs ($41K)
Type Security Shares Price Value
Grant/Award Class A Common Stock 26,643 $0.00 --
Sale Class A Common Stock 7,203 $5.70 $41K
Holdings After Transaction: Class A Common Stock — 69,636 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Shares sold 7,203 shares Open-market sale of Class A Common Stock on June 1, 2026
Sale price $5.70 per share Price for 7,203 shares sold on June 1, 2026
Shares granted 26,643 shares Grant/award acquisition of Class A Common Stock on June 1, 2026
Holdings after transactions 69,636 shares Direct Class A Common Stock holdings following June 1, 2026 transactions
Net shares sold 7,203 shares NetBuySellShares in transaction summary marked net-sell
open-market sale financial
"transaction_action: "open-market sale" for 7,203 Class A Common Stock"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
grant/award acquisition financial
"transaction_action: "grant/award acquisition" for 26,643 Class A Common Stock"
Rule 10b5-1(c) regulatory
"trading plan intended to comply with Rule 10b5-1(c) and adopted on February 19, 2026"
Rule 10b5-1(c) is an SEC guideline that lets company insiders set up a written, pre-planned schedule to buy or sell their company stock when they are not in possession of material, nonpublic information. For investors, it matters because such plans can reduce the appearance of insider trading by separating decisions from inside knowledge—like putting your trades on autopilot—while also requiring scrutiny since pre-planned trades can still affect market confidence and share value.
Class A Common Stock financial
"security_title: "Class A Common Stock" in both reported transactions"
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
WOODBURY EDWINA D

(Last)(First)(Middle)
C/O NU SKIN ENTERPRISES, INC.
75 W CENTER STREET

(Street)
PROVO UTAH 84601

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
NU SKIN ENTERPRISES, INC. [ NUS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/01/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Stock06/01/2026A26,643A$0.0069,636D
Class A Common Stock06/01/2026S7,203(1)D$5.762,433D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The reported transaction occurred pursuant to a trading plan intended to comply with Rule 10b5-1(c) and adopted on February 19, 2026.
/s/ Gregory Belliston as Attorney-in-Fact for Edwina D. Woodbury06/03/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transactions did Edwina D. Woodbury report for NUS?

Edwina D. Woodbury reported an open-market sale and a stock grant. She sold 7,203 shares of Class A Common Stock and received a grant of 26,643 shares, both dated June 1, 2026, changing her overall direct holdings.

How many Nu Skin (NUS) shares did the director sell and at what price?

She sold 7,203 shares of Nu Skin Class A Common Stock at $5.70 per share. This open-market transaction represents a relatively small portion of her overall holdings and was part of a broader set of transactions reported that day.

What stock grant did the Nu Skin (NUS) director receive on June 1, 2026?

She acquired 26,643 shares of Class A Common Stock through a grant or award, reported with a price of $0.00 per share. This compensation-related acquisition increased her direct ownership stake in Nu Skin beyond the shares sold.

What are Edwina D. Woodbury’s Nu Skin (NUS) holdings after these transactions?

After the reported sale and stock grant, her direct holdings total 69,636 shares of Nu Skin Class A Common Stock. This figure reflects the combined impact of selling 7,203 shares and receiving 26,643 shares through a grant or award.

Was the Nu Skin (NUS) director’s share sale under a Rule 10b5-1 plan?

Yes. The filing states the sale occurred under a trading plan intended to comply with Rule 10b5-1(c), adopted February 19, 2026. Such plans pre-schedule trades, making the sale’s timing more routine and less discretionary.

Did the Nu Skin (NUS) director trade any derivative securities in this filing?

No derivative securities are reported in this filing. The transactions involve only non-derivative Class A Common Stock: an open-market sale and a grant or award acquisition, with no listed options, warrants, or other derivatives.